Search

everythinglearnresearchcommunity

for

Search:↓

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Metformin is less effective in men with early-onset hair loss.

The weight loss drug Orlistat can cause liver damage and should be used with caution, especially in those with liver or kidney issues.

Oxidative stress plays a role in female pattern baldness, causing an imbalance between harmful and protective elements in the body.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Most diabetic patients have skin problems, which are more common with longer diabetes duration and poor blood sugar control.

Immune activities and specific genes are important in male pattern baldness.

The woman's hair loss is likely stress-related and should improve without treatment.

Almost half of the dermatology patients in Eastern Turkey use alternative medicine, which can be risky and delay proper treatment.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

Human hair protein modifications could potentially indicate heart disease risk.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.